Concepedia

Martin I. Freed

MI

39

Publications

5.3K

Citations

27

H-Index

1992

Active since

Affiliations

GlaxoSmithKline (United States)(Current)

New Frontier

University of Pennsylvania Health System

Penn Presbyterian Medical Center

The University of Texas Health Science Center at San Antonio

Martin I. Freed is an author at GlaxoSmithKline (United States) specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

Publications per year

1992–2016

39

Publications

39

Effect of Rosiglitazone Treatment on Nontraditional Markers of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus

Steven M. Haffner, Andrew S. Greenberg, Wayde M. Weston et al. · Circulation · 2002 · 877 citations · Full text

Rosiglitazone Monotherapy Is Effective in Patients with Type 2 Diabetes

Harold E. Lebovitz, Jo Dole, Rita Patwardhan et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 503 citations · Full text

A Randomized Trial of Rosiglitazone Therapy in Patients With Inadequately Controlled Insulin-Treated Type 2 Diabetes

Philip Raskin, Marc Rendell, Matthew C. Riddle et al. · Diabetes Care · 2001 · 343 citations · Full text

Improving Metabolic Control Leads to Better Working Memory in Adults With Type 2 Diabetes

Christopher M. Ryan, Martin I. Freed, Julie A. Rood et al. · Diabetes Care · 2006 · 287 citations

A Diabetes Outcome Progression Trial (ADOPT)

Giancarlo Viberti, Steven E. Kahn, Douglas A. Greene et al. · Diabetes Care · 2002 · 269 citations · Full text

Rows per page

1–5 of 39